Cardiology Department, University Clinical Center of Serbia, Belgrade, Serbia.
Belgrade Medical Faculty, University of Belgrade, Belgrade, Serbia.
Expert Rev Cardiovasc Ther. 2022 Oct;20(10):787-793. doi: 10.1080/14779072.2022.2137491. Epub 2022 Oct 24.
Although guidelines recommend a watchful waiting strategy for patients with asymptomatic severe aortic stenosis, there have been considerable advancements in surgical and anesthetic techniques along with the success of transcatheter aortic valve replacement (AVR) as a viable alternative to surgical AVR. Inevitably, these developments have raised questions as to whether or not there is still merit in waiting for symptoms to ensue before treatment may be offered to these patients.
The principal purpose of this paper is to review the data supporting earlier intervention in patients with asymptomatic severe aortic stenosis, and to project the implications these and other ongoing trials will have on indications for AVR in asymptomatic patients in the future.
The threshold for intervention in certain subgroups of asymptomatic patients with severe AS has already been lowered. The next frontier will inevitably be determining whether all patients with severe AS should undergo AVR irrespective of their symptomatic status.
尽管指南建议对无症状严重主动脉瓣狭窄患者采取观察等待策略,但随着手术和麻醉技术的不断进步,以及经导管主动脉瓣置换术(TAVR)作为一种可行的手术主动脉瓣置换术替代方法的成功,这些发展不可避免地引发了一些问题,即是否仍有必要等待症状出现后再为这些患者提供治疗。
本文的主要目的是回顾支持对无症状严重主动脉瓣狭窄患者进行早期干预的数据,并预测这些数据和其他正在进行的试验将对未来无症状患者进行主动脉瓣置换术的适应证产生的影响。
某些亚组无症状严重主动脉瓣狭窄患者的干预阈值已经降低。下一个前沿领域将不可避免地是确定是否所有严重主动脉瓣狭窄患者无论其症状如何都应接受主动脉瓣置换术。